{"id":171855,"date":"2025-10-27T09:36:50","date_gmt":"2025-10-27T13:36:50","guid":{"rendered":"https:\/\/44.250.171.167\/?p=171855"},"modified":"2025-10-27T09:36:50","modified_gmt":"2025-10-27T13:36:50","slug":"bajaj-healthcare-q2-fy26-earnings-results","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/bajaj-healthcare-q2-fy26-earnings-results\/","title":{"rendered":"Bajaj Healthcare\u00a0Q2 FY26 Earnings Results"},"content":{"rendered":"<p>Bajaj Healthcare Ltd, incorporated in 1993, specializes in the production of Active Pharmaceutical Ingredients (APIs) and pharmaceutical formulations with a strong global footprint. The company supplies to both advanced and emerging markets, ensuring regulatory compliance and product innovation.<\/p>\n<h2><strong>Q2 FY26 Earnings Summary\u00a0<\/strong><\/h2>\n<ul>\n<li>Consolidated revenue grew 11.28% year on year to \u20b9148 crore, up from \u20b9133 crore.<u>\\<\/u>\u200b<\/li>\n<li>Total expenses increased 8.06% to \u20b9134 crore, compared to \u20b9124 crore last year.<\/li>\n<li>Consolidated net <a href=\"https:\/\/www.bseindia.com\/xml-data\/corpfiling\/AttachHis\/bcf53eed-0fb6-4013-a458-298bf758c01e.pdf\" target=\"_blank\" rel=\"noopener\">profit<\/a> rose 22.22% to \u20b911 crore, versus \u20b99 crore in Q2 FY25.<\/li>\n<li>Earnings per share (EPS) was \u20b93.52, up 17.33% from \u20b93.00 a year ago.<\/li>\n<\/ul>\n<h2><strong>Operational and Business Highlights<\/strong><\/h2>\n<ul>\n<li>Q2 FY26 saw strong growth in API exports (up 67% YoY), offsetting a slight decline in domestic API performance.<\/li>\n<li>Formulation business remained stable with ongoing resilience despite a minor revenue dip.<\/li>\n<li>Margin expansion was driven by higher export volumes and operational efficiencies. Gross margin improved sequentially by 462 basis points to 50.8%. EBITDA margin expanded to 19.1%.<a href=\"https:\/\/www.icicidirect.com\/research\/equity\/rapid-results\/bajaj-healthcare-ltd\" target=\"_blank\" rel=\"noopener\">icicidirect+1<\/a>\u200b<\/li>\n<li>Bajaj Healthcare received key regulatory nods: phase III clinical trials for Suvorexant and Cenobamate tablets, as well as new CEP and DMF filings in regulated markets.<\/li>\n<\/ul>\n<h2><strong>Financial Strength and Outlook<\/strong><\/h2>\n<ul>\n<li>The company maintained a solid balance sheet, enhanced regulatory preparedness, and strategic investments in R&amp;D.<\/li>\n<li>Management remains focused on expanding product registrations and targeting high-value therapeutic areas for long-term growth.<\/li>\n<li>Bajaj Healthcare continues to leverage its global presence, compliance, and innovation to sustain earnings growth through FY26 and beyond.<\/li>\n<\/ul>\n<p>Explore the company\u2019s past earnings and latest concall transcripts, <a href=\"https:\/\/44.250.171.167\/symbol\/bajajhcare\/\">click here<\/a> to visit the AlphaStreet India News Channel.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-171857\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/10\/BAJ.png\" alt=\"Q2 FY26 \" width=\"1489\" height=\"1817\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/10\/BAJ.png 1489w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/10\/BAJ-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/10\/BAJ-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/10\/BAJ-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/10\/BAJ-1259x1536.png 1259w\" sizes=\"auto, (max-width: 1489px) 100vw, 1489px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bajaj Healthcare Ltd, incorporated in 1993, specializes in the production of Active Pharmaceutical Ingredients (APIs) and pharmaceutical formulations with a strong global footprint. The company supplies to both advanced and emerging markets, ensuring regulatory compliance and product innovation. Q2 FY26 Earnings Summary\u00a0 Consolidated revenue grew 11.28% year on year to \u20b9148 crore, up from \u20b9133 [&hellip;]<\/p>\n","protected":false},"author":1932,"featured_media":171857,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392],"tags":[11776],"class_list":["post-171855","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","tag-active-pharmaceutical-ingredients"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2025\/10\/BAJ.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":172455,"url":"https:\/\/alphastreet.com\/india\/granules-india-q2-fy26-earnings-results\/","url_meta":{"origin":171855,"position":0},"title":"Granules India Q2 FY26 Earnings Results","author":"Divyansh_Kasana","date":"November 18, 2025","format":false,"excerpt":"Granules India Ltd and its subsidiaries, specializing in Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages, posted impressive financial results for Q2FY26. Financial Highlights: Revenues increased 34.13% year-on-year to \u20b91,297 crore from \u20b9967 crore. Total expenses rose 33.02% to \u20b91,120 crore from \u20b9842 crore. Consolidated net profit\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Q2 FY26","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/G-6.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/G-6.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/G-6.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/G-6.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/G-6.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/G-6.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":172578,"url":"https:\/\/alphastreet.com\/india\/bajaj-electricals-q2-fy26-earnings-results\/","url_meta":{"origin":171855,"position":1},"title":"Bajaj Electricals Q2 FY26 Earnings Results","author":"Divyansh_Kasana","date":"November 20, 2025","format":false,"excerpt":"Bajaj Electricals Limited, part of the Bajaj Group and a leading FMEG player with diversified presence across consumer products and EPC segments including brands like Morphy Richards and Nirlep, reported a drop in profits for Q2FY26. Financial Highlights: Revenues declined 1.0% year-on-year to \u20b91,107.14 crore from \u20b91,118.33 crore. Total expenses\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Q2 FY26","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/BAJ.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/BAJ.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/BAJ.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/BAJ.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/BAJ.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/BAJ.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":171740,"url":"https:\/\/alphastreet.com\/india\/rpg-life-sciences-q2-fy26-earnings-results\/","url_meta":{"origin":171855,"position":2},"title":"RPG Life Sciences Q2 FY26 Earnings Results","author":"Chirag Gupta","date":"October 22, 2025","format":false,"excerpt":"Incorporated in 2007, RPG Life Sciences Ltd manufactures and markets Formulations (Finished Dosage Forms) and Active Pharma Ingredients. Presenting below are its Q2 FY26 earnings results. \u00a0 Q2 FY26 Earnings Results Revenue from Operations:\u00a0\u20b9181.7 crore, up\u00a05.5% YoY\u00a0from \u20b9172.2 crore and\u00a07.6% QoQ\u00a0from \u20b9168.9 crore in Q1 FY26, driven by strong domestic\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"RPG Life Sciences Q2 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/10\/RPG-Life-Sciences-Q2-FY26-Earnings-Results.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/10\/RPG-Life-Sciences-Q2-FY26-Earnings-Results.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/10\/RPG-Life-Sciences-Q2-FY26-Earnings-Results.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/10\/RPG-Life-Sciences-Q2-FY26-Earnings-Results.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/10\/RPG-Life-Sciences-Q2-FY26-Earnings-Results.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/10\/RPG-Life-Sciences-Q2-FY26-Earnings-Results.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":172258,"url":"https:\/\/alphastreet.com\/india\/bajaj-auto-q2-fy26-earnings-results\/","url_meta":{"origin":171855,"position":3},"title":"Bajaj Auto Q2 FY26 Earnings Results","author":"Divyansh_Kasana","date":"November 10, 2025","format":false,"excerpt":"Bajaj Auto Ltd, the flagship entity of the Bajaj Group and a leading manufacturer of two-wheelers and three-wheelers with exports to 79 countries including Latin America and Southeast Asia, reported strong financial results for Q2FY26. Financial Highlights: Revenues increased 18.78% year-on-year to \u20b915,735 crore from \u20b913,247 crore. Total expenses rose\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Q2 FY26","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/b-2.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/b-2.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/b-2.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/b-2.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/b-2.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/11\/b-2.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":172881,"url":"https:\/\/alphastreet.com\/india\/akums-drugs-q2-fy26-earnings-results\/","url_meta":{"origin":171855,"position":4},"title":"Akums Drugs Q2 FY26 Earnings Results","author":"Divyansh_Kasana","date":"December 3, 2025","format":false,"excerpt":"Akums Drugs & Pharmaceuticals Ltd, established in 2004 as India's leading pharmaceutical CDMO offering comprehensive product development and manufacturing services across formulations, reported lower profitability for Q2FY26. Financial Highlights: Revenues declined 1.45% year-on-year to \u20b91,018 crore from \u20b91,033 crore, with CDMO up 0.7% to \u20b9804 crore but API\/international formulations down.\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"Q2 FY26","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/12\/AK.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/12\/AK.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/12\/AK.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/12\/AK.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/12\/AK.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/12\/AK.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/171855","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=171855"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/171855\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/171857"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=171855"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=171855"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=171855"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}